ClinicalTrials.gg
Status unknownNCT04630184SPA-VRUpdated Nov 3, 2022

A Virtual Reality Exposure Intervention on Social Physical Anxiety in Women With Obesity

An interventional study of Exposure intervention in virtual reality and Exercise in Obesity, Exercise and Virtual Reality, sponsored by Universite du Quebec en Outaouais. Status unknown at 1 site in Canada. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-11-03.

Sponsored by Universite du Quebec en Outaouais · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Oct 2022), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 575 studies in Obesity with a site in Canada — 102 open to participants now, 151 under way, 47 of them phase 3. Obesity · Canada.

Planned enrollment
309th of 480
45 · median 74
Started
2021
with 29 others
No phase
280 of 575
34 open now
Registered
360th of 575
by date

Among the 575 studies in Obesity with a site in Canada, this one is the 309th largest by planned enrollment of the 480 interventional ones that give a count, is one of 30 that started in 2021, is one of 280 with no phase, and was the 360th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

102 of the 575 studies in Obesity with a site in Canada are open now. Recruiting first, the newest first:

97 more — sign in →

All 102 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 575 studies in Obesity with a site in Canada, or all of them as a file.
02

Study summary

The objectives of the project are to: i) assess the feasibility and acceptability of the protocol and the VR exposure intervention in women with obesity, and ii) obtain an estimate of the effect of VR exposure intervention associated with an exercise training on SPA, compliance, adherence and persistence to the exercise training, as well as persistence in PA practice in the middle term to calculate the sample size for a future larger randomized controlled trial (RCT) in women with obesity.

A RCT of feasibility will be carried out. Forty-five women with obesity and a high level of SPA will be randomized into one of the following three groups: 1) Exercice and VR exposure (Ex + expo), 2) Exercise and psychological intervention control (Ex + control) or 3) waiting list (WL).

The interventions will have a physical exercise training (identical for all) and a psychology intervention (different according to the condition: VR exposure or control). The feasibility and acceptability of the protocol and the VR exposure intervention will be assessed at the end of the study. SPA, PA practice, anthropometry, internalization of weight bias, body appreciation, perceived pleasure, motivational regulation, self-efficacy, affects as well as perception effort will be evaluated with questionnaires and scales validated before and after the intervention and 6 months after the end of the intervention. Sociodemographic data, depressive symptoms, problematic eating behaviors and propensity to immersion will be assessed during the initial visit only. Adherence, adherence and persistence to the PA program will be calculated at the end of the intervention. Persistence in PA practice will be calculated using data collected immediately after the end of the intervention and 6 months after the intervention.

Read the detailed description

Several studies show that a high level of social physical anxiety (SPA) can lead to avoidance and poor adherence to physical activity (PA) programs. Although this link is known and a high level of SPA is frequently found in women with obesity, no psychological intervention specific to the treatment of SPA has been developed to date. Exposure therapy is the treatment of choice for general social anxiety. However, this format of therapy can cause great discomfort for the patient and prevents complete control of the environment by the clinician. Virtual reality (VR), commonly employed in the treatment of anxiety disorders, offers a solution to these problems by allowing exposure to human stimuli in an adaptable environment and under the control of the clinician, with a reduction in stress patient discomfort.

The objectives of the project are to: i) assess the feasibility and acceptability of the protocol and the VR exposure intervention in women with obesity, and ii) obtain an estimate of the effect of VR exposure intervention associated with an exercise training on SPA, compliance, adherence and persistence to the exercise training, as well as persistence in PA practice in the middle term to calculate the sample size for a future larger randomized controlled trial (RCT) in women with obesity.

A RCT of feasibility will be carried out. Forty-five women with obesity and a high level of SPA will be randomized into one of the following three groups: 1) Exercice and VR exposure (Ex + expo), 2) Exercise and psychological intervention control (Ex + control) or 3) waiting list (WL).

The interventions will have a physical exercise training (identical for all) and a psychology intervention (different according to the condition: VR exposure or control). The feasibility and acceptability of the protocol and the VR exposure intervention will be assessed at the end of the study. SPA, PA practice, anthropometry, internalization of weight bias, body appreciation, perceived pleasure, motivational regulation, self-efficacy, affects as well as perception effort will be evaluated with questionnaires and scales validated before and after the intervention and 6 months after the end of the intervention. Sociodemographic data, depressive symptoms, problematic eating behaviors and propensity to immersion will be assessed during the initial visit only. Adherence, adherence and persistence to the PA program will be calculated at the end of the intervention. Persistence in PA practice will be calculated using data collected immediately after the end of the intervention and 6 months after the intervention.

03

Conditions studied

  • Obesity
  • Exercise
  • Virtual Reality
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • woman
  • inactive (\<150 min. of moderate to vigorous PA / week )
  • aged between 18 and 45 years
  • ≥ 30 kg / m2
  • to be able to go to Université du Québec en Outaouais twice a week

Exclusion criteria

Exclusion Criteria:

  • to have a low to moderate social physical anxiety level (SPA score \<27/45 on the physical and social anxiety scale )
  • suffer from to motion sickness
  • to be pregnant or plan to become over the next year
  • to take medication that may influence weight
  • to have undergone bariatric surgery
  • to have a to physical activity
  • to have participated in a physical activity program in the last 6 months supervised
  • to have an intellectual disability, and have a severe and persistent psychiatric problem (psychosis, bipolar disorder).
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    Virtual reality and exercice

    This group will receive the exposure intervention in virtual reality and physical activity during 12 weeks

    Behavioral: Exposure intervention in virtual reality · Behavioral: Exercise

  • Placebo comparator
    Placebo and exercice

    This group will receive the placebo intervention (relaxation) and physical activity during 12 weeks

    Behavioral: Exercise · Behavioral: Placebo

  • No intervention
    waiting list

    This group will receive no intervention during 12 weeks, then will be randomized in the experimental or placebo group

Interventions

  • BehavioralExposure intervention in virtual reality

    6 sessions of 45 minutes weekly and 2 follow-up meetings (3 and 6 weeks after the weekly follow-up) with cognitive restructuring and VR exposure supervised by psychologists

  • BehavioralExercise

    Participants will have to go twice a week, for 12 weeks to carry out 2 individual endurance training sessions of 45 minutes (moderate to vigorous intensity), supervised by a kinesiologist. Participants will also have to complete a 3rd 60-minute endurance session at home (or two 30-minute sessions).

  • BehavioralPlacebo

    6 sessions of 45 minutes weekly and 2 follow-up meetings (3 and 6 weeks after the weekly follow-up) Discussion around social physical anxiety, stress management (relaxation and breathing) supervised by psychologists

06

What researchers measure

Primary outcomes

  1. Feasibility of the protocol and the intervention

    The feasibility of the protocol will be assessed at the end of the study using the following criteria: i) the recruitment rate (number of participants recruited per month), ii) the retention rate (number of participants who have completed all the assessments and focus group and reason for dropout), iii) percentage of missing data (number of missing data out of number of total data) and iv) acceptance of randomization. The feasibility of the intervention will be evaluated at the end of the study using the following criteria: v) the participation rate (number of eligible participants who agreed to participate in the study), vi) the participation rate adherence (number of participants who completed the 8 psychological intervention sessions), vii) the attrition rate (number of participants who abandoned the psychological intervention and reasons). The achievement of the following criteria will be considered as a success factor in terms of feasibility (14, 23): i) recruitment rate ≤ 5.6,

    Time frame: At the end of the study (+ 36 weeks)

  2. Acceptability of the protocol and the intervention

    The acceptability of the protocol and the intervention will be qualitatively assessed through 5 to 7 semi-structured discussion groups by teleconference via the zoom platform. The participants will be interviewed for 75 minutes in sub-groups of 6 to 8 participants on their perception, opinion and experience regarding the intervention and the implementation of the protocol (barriers, facilitators, satisfaction, perceived benefits, recommendation and improvement). An interview guide constructed for the purpose of the study will ensure consistency of the themes explored between the different groups while guiding the group facilitation.

    Time frame: At the end of the intervention (+ 12 weeks)

Secondary outcomes

  1. Social physical anxiety change (0-12 weeks)

    Social physical anxiety scale (validated questionnaire)

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  2. Adherence to the physical activity (PA) intervention

    Adherence to the PA intervention will be calculated as a percentage from the total number of sessions performed out of the 36 prescribed sessions (frequency).

    Time frame: At the end of the PA intervention (after 12 weeks)

  3. Compliance with the PA intervention

    Compliance with the PA intervention will be calculated as a percentage from the number of sessions for which the participant will have prescribed the prescription compared to all sessions. For these calculations, data from heart rate monitors worn by participants during PA sessions and diaries completed by participants and the kinesiologist will be used.

    Time frame: At the end of the PA intervention (after 12 weeks)

  4. Physical activity change (0-12 weeks)

    Triaxial accelerometer (Actigraph® wGT3X-BT) worn on the hip for 7 days

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  5. Persistance in the practice of PA after the intervention

    Triaxial accelerometer (Actigraph® wGT3X-BT) worn on the hip for 7 days

    Time frame: Immediately after the intervention and at the end of the study (after 12 weeks and 36 weeks)

Other outcomes

  1. Propensity to immersion

    Validated questionnaire

    Time frame: Before the intervention (baseline)

  2. The feeling of presence in immersion the feeling of presence in immersion

    Gatineau presence questionnaire

    Time frame: after each virtual reality session (weeks 1, 2, 3, 4, 5,6 , 9 amd 12)

  3. Cybermalaise

    Simulator Sickness Questionnaire

    Time frame: before and after each virtual reality session (weeks 1, 2, 3, 4, 5,6 , 9 amd 12)

  4. Sociodemographic data

    age, sex,ethnocultural group, level of education, professional status

    Time frame: before the intervention (baseline)

  5. Depressive symptoms

    Center Epidémiologic Scale-Depression-French ; scale (0-3) score range (0-60) higher score = higher depressive symptoms

    Time frame: before the intervention (baseline)

  6. Food disorder

    Eating Attitudes Test-26 ; scale (0-3) score range (0-78), Higher scores indicating greater risk of an eating disorder

    Time frame: before the intervention (baseline)

  7. Weight Bias Internalisation change (0-12 weeks)

    Modified Weight Bias Internalisation Scale, scale (1-7), range score (11-77), higher score = higher Weight Bias Internalization)

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  8. Body composition change (0-12 weeks)

    bio-impedance balance (Tanita MC 780U) made by research assistant

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  9. Body index mass change (0-12 weeks)

    scale and measuring rod to measure the size made by research assistant

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  10. Waist circumference change (0-12 weeks)

    tape measure made by research assistant

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  11. Body Appreciation change (0-12 weeks)

    Body Appreciation Scale-2, scale (1-5) score range (1-5), higher score = higher body satisfaction

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  12. Perceived pleasure in physical activity in general (0-12 weeks)

    Physical Activity Enjoyment Scale, scale (1-7) score (1-7) higher score = higher enjoyment

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  13. Motivation change (0-12 weeks)

    Behavioural Regulation In Exercise Questionnaire, scale (0-4), Higher, positive scores indicate greater relative autonomy; lower, negative scores indicate more controlled regulation.

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  14. Affects during exercise change (0-12 weeks)

    Felt Arousal Scale (score 1-6) higher score = higher felt arousal + Feeling Scale (score -5,5) higher score higher pleasure

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  15. Self-efficacy change (0-12 weeks)

    Self efficacy scale (Bandura), scale (0-100) score range (0-100) higher score = higher self efficacy

    Time frame: Before and after intervention (Baseline and after 12 weeks)

  16. Perception effort change (0-12 weeks)

    Borg scale, scale and score range (0-10), higher score = higher perception of effort

    Time frame: Before and after intervention (Baseline and after 12 weeks)

07

Study locations

1 of 1 sites recruiting
  • UQO
    Gatineau, Quebec J8X 3X7, Canada
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2021 (actual). Primary completion is estimated for Mar 2023, 18 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 18 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2020
First posted
Nov 16, 2020
StartActual
Sep 1, 2021
Primary completionEst.
Mar 31, 2023
CompletionEst.
Dec 31, 2023
Last update
Nov 3, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04630184
Lead sponsor
Universite du Quebec en Outaouais
Responsible party
Aurelie Baillot (Professor, Universite du Quebec en Outaouais) — Principal investigator
First posted
Nov 16, 2020
Start date
Sep 1, 2021
Primary completion
Mar 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Nov 3, 2022

Study contacts

aurelie Baillot
Contact
aurelie.baillot@uqo.ca
8199437561

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion